4processed

Form 4 — Insider Transaction

Sensei Biotherapeutics, Inc.(SNSE)

Filing Date

February 17, 2026

Accepted

February 17, 2026

Accession No.

0002111813-26-000008

CIK

0001829802

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Parikh Anand KiranPresident and CEOOther761.428761.4KSeries B Preferred StockFeb 17, 2026
Parikh Anand KiranPresident and CEOOther12.3K12.3KEmployee Stock Option (right to buy)Feb 17, 2026
Parikh Anand KiranPresident and CEOOther136.9K136.9KEmployee Stock Option (right to buy)Feb 17, 2026